Evidence map›Paper›PMID 22447928›Full record

ArticleThe Journal of biological chemistry2012

TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.

Anguo Liu, Ping Gong, Sang W Hyun, Kent Z Q Wang, Elizabeth A Cates, Darren Perkins, Douglas D Bannerman, Adam C Puché, Vladimir Y Toshchakov, Shengyun Fang and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmaceutical biology · 2021
    Article
  6. Tril dampens Nodal signaling through Pellino2- and Traf6-mediated activation of Nedd4l.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Tau Ubiquitination in Alzheimer's Disease.Frontiers in neurology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Biological and pathophysiological roles of end-products of DHA oxidation.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Anguo LiuMucosal Biology Research Center, University of Maryland, Baltimore, Maryland 21201, USA.
Ping Gong
Sang W Hyun
Kent Z Q Wang
Elizabeth A Cates
Darren Perkins
Douglas D Bannerman
Adam C Puché
Vladimir Y Toshchakov
Shengyun Fang
Philip E Auron
Stefanie N Vogel
Simeon E Goldblum
University of Maryland, Baltimore · USDuquesne University · USUniversity of Maryland, College Park · USVA Maryland Health Care System · US

Funding

DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATIONR37AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2000 to 2009
$5.3M
Deciphering the architecture of TLR signaling complexesR01AI082299 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI TOSHCHAKOV, VLADIMIR Y. · 2010 to 2020
$3.8M
DIFFERENTIATIVE SIGNALS FOR MACROPHANGE ACTIVATIONR01AI018797 · NIAID · U.S. UNIFORMED SERVICES UNIV OF HLTH SCI · PI VOGEL, STEFANIE N. · 1985 to 2014
$3.8M
Endotoxin TLR4 Signaling Regulates Lung Endothelial Paracellular PathwayR01HL089179 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI GOLDBLUM, SIMEON EMANUEL · 2009 to 2012
$1.5M
Differentiative Signals for Macrophage ActivationR56AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2015 to 2015
$506k
NEU1 Sialidase Disrupts CD31-Driven Angiogenesis in Human Lung EndotheliaI01BX002352 · VA · BALTIMORE VA MEDICAL CENTER · PI GOLDBLUM, SIMEON EMANUEL · 2015 to 2018
–
BLRD VA I01 BX002352NHLBI NIH HHS HL089179NHLBI NIH HHS R01 HL089179NIAID NIH HHS AI082299NIAID NIH HHS AI18797NIAID NIH HHS R01 AI018797NIAID NIH HHS R01 AI082299NIAID NIH HHS R37 AI018797NIAID NIH HHS R56 AI018797
6 · The paper itself

Abstract

Gram-negative bacteria release lipopolysaccharide (LPS) into the bloodstream. Here, it engages Toll-like receptor (TLR) 4 expressed in human lung microvascular endothelia (HMVEC-Ls) to open the paracellular pathway through Src family kinase (SFK) activation. The signaling molecules that couple TLR4 to the SFK-driven barrier disruption are unknown. In HMVEC-Ls, siRNA-induced silencing of TIRAP/Mal and overexpression of dominant-negative TIRAP/Mal each blocked LPS-induced SFK activation and increases in transendothelial [(14)C]albumin flux, implicating the MyD88-dependent pathway. LPS increased TRAF6 autoubiquitination and binding to IRAK1. Silencing of TRAF6, TRAF6-dominant-negative overexpression, or preincubation of HMVEC-Ls with a cell-permeable TRAF6 decoy peptide decreased both LPS-induced SFK activation and barrier disruption. LPS increased binding of both c-Src and Fyn to GST-TRAF6 but not to a GST-TRAF6 mutant in which the three prolines in the putative Src homology 3 domain-binding motif (amino acids 461-469) were substituted with alanines. A cell-permeable decoy peptide corresponding to the same proline-rich motif reduced SFK binding to WT GST-TRAF6 compared with the Pro → Ala-substituted peptide. Finally, LPS increased binding of activated Tyr(P)(416)-SFK to GST-TRAF6, and preincubation of HMVEC-Ls with SFK-selective tyrosine kinase inhibitors, PP2 and SU6656, diminished TRAF6 binding to c-Src and Fyn. During the TRAF6-SFK association, TRAF6 catalyzed Lys(63)-linked ubiquitination of c-Src and Fyn, whereas SFK activation increased tyrosine phosphorylation of TRAF6. The TRAF6 decoy peptide blocked both LPS-induced SFK ubiquitination and TRAF6 phosphorylation. Together, these data indicate that the proline-rich Src homology 3 domain-binding motif in TRAF6 interacts directly with activated SFKs to couple LPS engagement of TLR4 to SFK activation and loss of barrier integrity in HMVEC-Ls.

Indexed as

Amino Acid MotifsCapillary PermeabilityCells, CulturedEndothelial CellsEnzyme ActivationGene SilencingHumansInterleukin-1 Receptor-Associated KinasesLipopolysaccharidesLungMembrane GlycoproteinsMyeloid Differentiation Factor 88PeptidesProtein BindingProto-Oncogene Proteins c-fynReceptors, Interleukin-1FYN protein, humanInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanLipopolysaccharidesMembrane GlycoproteinsMYD88 protein, humanMyeloid Differentiation Factor 88PeptidesProto-Oncogene Proteins c-fynReceptors, Interleukin-1src-Family KinasesTIRAP protein, humanTLR4 protein, humanTNF Receptor-Associated Factor 6Toll-Like Receptor 4

Identifiers

PMID22447928
PMCPMC3351307
OpenAlexW2041313758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.